FMP
Dec 5, 2023 3:34 PM - Davit Kirakosyan(Last modified: Dec 19, 2023 5:49 PM)
Image credit: FMP
CVS Health (NYSE:CVS) projected its 2024 revenue to surpass current market expectations, aiming for at least $366 billion compared to the Street's estimate of $345.5 billion. The company is also targeting an adjusted earnings per share (EPS) of at least $8.50 for 2024, aligning with consensus forecasts. Moreover, CVS Health anticipates generating a minimum of $12.5 billion in operational cash flow. These projections were announced ahead of CVS Health's 2023 Investor Day.
Following this announcement, CVS shares experienced a more than 3% increase intra-day today.
Additionally, CVS Health plans to introduce a novel pharmacy reimbursement model named CVS CostVantage. This model aims to transform the traditional reimbursement framework, emphasizing enhanced transparency and simplicity.
Furthermore, CVS Health reaffirmed its financial outlook for 2023. The company maintains its adjusted EPS forecast at around $8.60, with a possible variation of 10 cents, and anticipates revenues to be in the range of $351.5 to $357.3 billion. These figures are in line with the average analyst estimate, which predicts an EPS of $8.60 on revenues of approximately $353.7 billion.
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...
May 16, 2024 8:06 PM - Gordon Thompson
On Thursday, May 16, 2024, Deutsche Bank upgraded its rating on NASDAQ:ASTS to Buy, maintaining a hold position. At the time of the announcement, ASTS was trading at $4.03. This decision was accompanied by an increase in the price target for AST SpaceMobile, raised to $22 from $19, as detailed in a ...
May 24, 2024 9:30 AM - Rajnish Katharotiya
Earnings call transcripts are invaluable resources for investors, analysts, and financial enthusiasts. They provide insights into a company's performance, strategy, and future outlook, making them essential for making informed investment decisions. With Financial Modeling Prep, Earnings Call Transcr...